Scarica l'app Stockscreener
4.13
0.00%
0.00
Dopo l'orario di chiusura:
4.12
-0.010
-0.24%
Precedente Chiudi:
$4.13
Aprire:
$4.06
Volume 24 ore:
913.39K
Relative Volume:
0.20
Capitalizzazione di mercato:
$504.05M
Reddito:
$44.55M
Utile/perdita netta:
$-83.78M
Rapporto P/E:
-5.3126
EPS:
-0.7774
Flusso di cassa netto:
$-52.99M
1 W Prestazione:
-0.24%
1M Prestazione:
-1.90%
6M Prestazione:
-28.42%
1 anno Prestazione:
+35.86%
Intervallo 1D:
$4.04
$4.175
Intervallo di 1 settimana:
$3.94
$4.24
Portata 52W:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Nome
Aquestive Therapeutics Inc
Settore
Telefono
908-941-1900
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.13 | 504.05M | 44.55M | -83.78M | -52.99M | -0.7774 |
TAK
Takeda Pharmaceutical Co Adr
|
18.74 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
117.94 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.93 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.08 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
564.81 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-28 | Iniziato | Raymond James | Outperform |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-04-22 | Iniziato | H.C. Wainwright | Buy |
| 2019-01-03 | Iniziato | Lake Street | Buy |
| 2018-08-20 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-08-20 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
2026-04-05 | AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Aquestive Therapeutics, Inc. to Contact the Firm Today! | NDAQ:AQST | Press Release - Stockhouse
Published on: 2026-04-05 15:45:00 - baoquankhu1.vn
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Aquestive Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
AQST SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire
Bernstein Liebhard LLP Reminds Aquestive Shareholders of Lawsuit - National Today
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - bdtonline.com
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) ... - bdtonline.com
AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - ChartMill
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Aquestive Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
Aquestive Therapeutics, Inc. (AQST) stock price, news, quote and history - Yahoo Finance UK
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - ChartMill
AQST Stockholders Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive - GlobeNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky - PR Newswire
AQST Stock Price, Quote & Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST - ChartMill
User - The Chronicle-Journal
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline - TipRanks
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Insmed (INSM) - The Globe and Mail
AQST Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire
AQST Shareholders Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST) - TMX Newsfile
Analysts Are Bullish on These Healthcare Stocks: Alumis Inc. (ALMS), Aquestive Therapeutics (AQST) - The Globe and Mail
AQST Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aquestive Therapeutics, Inc. Securities Lawsuit — The Gross Law Firm - Morningstar
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3 - Insider Monkey
ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive Therapeutic - The National Law Review
AQST PE Ratio & Valuation, Is AQST Overvalued - Intellectia AI
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
AQST Investor Alert: Aquestive Therapeutics Faces Securities Fraud Lawsuit - National Today
Bragar Eagel & Squire Urges Aquestive Investors to Contact Firm Before Deadline - National Today
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Significant ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, - GlobeNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - GlobeNewswire
Aquestive Therapeutics Completes FDA Type A Meeting for Anaphylm, Plans NDA Resubmission in Q3 2026 - Minichart
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting - TipRanks
Aquestive Therapeutics | 8-K: Current report - Moomoo
Aquestive Therapeutics Receives FDA's Preliminary Comments on Anaphylm Study Designs - marketscreener.com
Aquestive reaffirms Q3 2026 NDA resubmission for Anaphylm By Investing.com - Investing.com Canada
Aquestive completes Type A FDA meeting, reaffirms Q3 2026 Anaphylm NDA resubmission - TradingView
FDA Type A meeting guides Aquestive (NASDAQ: AQST) Anaphylm NDA path - Stock Titan
Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film - Yahoo Finance
AQST Stock Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
ROSEN Law Firm Urges Aquestive Therapeutics Investors to Seek Legal Counsel - National Today
ROSEN, THE FIRST FILING FIRM, Encourages Franklin BSP Realty Trust, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FBRT - GlobeNewswire Inc.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aquestive - GlobeNewswire
Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):